OR WAIT 15 SECS
Tosoh Bioscience LLC (King of Prussia, Pennsylvania) has invested in Semba Biosciences (Madison, Wisconsin) with the intention of acquiring full ownership.
Tosoh Bioscience LLC (King of Prussia, Pennsylvania) has invested in Semba Biosciences (Madison, Wisconsin) with the intention of acquiring full ownership. The transaction was approved by the Board of Directors of both companies and an equity participation agreement was executed in November.
Tosoh and Semba have been collaborating on various downstream biomanufacturing projects since 2007.
Semba Biosciences President Robert Mierendorf said in a statement that his company is pleased to team up with Tosoh Bioscience to offer customers an advanced platform for multicolumn continuous biochromatography. The technologies of both companies fit perfectly together, he said, to provide an integrated solution for bioprocess research, development, and continuous manufacturing.
Ali Soleymannezhad, the director of sales and marketing at Tosoh, also expressed optimism about the deal. “By combining Semba Biosciences’ advanced Simulated Moving Bed technology with Tosoh Bioscience’s best-in-class resins, we will be able to offer the most productive and the most efficient solution in bioprocess chromatography while maintaining the highest quality,” he said.